Sunday, January 11, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Truist Securities Analyst Reaffirms Hold Rating on Sunrun with Updated Price Target

Elaine Mendonca by Elaine Mendonca
February 26, 2024
in Breaking News
0
Finances-and-tech
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter

Truist Securities analyst Jordan Levy recently reaffirmed a Hold rating on Sunrun (NASDAQ: RUN) and adjusted the price target to $14 on February 26, 2024. This update comes after a previous downgrade from Buy to Hold with a price target of $12 on October 4, 2023. Back on May 9, 2023, Truist Securities had initially recommended a Buy for Sunrun before the subsequent adjustments.

RUN Stock Shows Positive Momentum on February 26, 2024: A Promising Sign for Investors

On February 26, 2024, Run stock (RUN) showed some positive momentum in its performance. Despite trading near the bottom of its 52-week range and below its 200-day simple moving average, the stock managed to see a slight increase in its price.

At the opening of the market, RUN was priced at $11.71, which was $0.19 lower than its previous close. However, throughout the trading day, the stock saw a price increase of $0.02, resulting in a 0.17% rise in its value since the market last closed.

While the increase may seem small, it is a positive sign for investors as it shows that there is some upward movement in the stock’s performance. This could be attributed to various factors such as positive news about the company, changes in market conditions, or investor sentiment.

It is important to note that even though the stock is trading near the bottom of its 52-week range, this does not necessarily mean that it is a bad investment. Investors should consider other factors such as the company’s financial health, growth prospects, and industry trends before making any investment decisions.

Overall, the slight increase in RUN stock on February 26, 2024, is a positive sign for investors. It will be interesting to see how the stock performs in the coming days and whether it can sustain this upward momentum.

Run Stock Performance Review: Flat Revenue, Improved Net Income, and Increased EPS on February 26, 2024

On February 26, 2024, Run stock experienced mixed performances based on the financial data provided by CNN Money. Total revenue for Run stood at $2.26 billion for the past year, remaining flat compared to the previous year. Similarly, total revenue for the last quarter was $516.59 million, also holding flat since the previous quarter.

In terms of net income, Run reported a net loss of $1.60 billion for the past year, representing a significant decrease of 1025.44% compared to the previous year. However, the net loss for the last quarter improved to $350.12 million, indicating a 67.26% increase from the previous quarter.

Earnings per share (EPS) for Run showed a similar trend. The EPS for the past year was -$7.41, reflecting a decrease of 1036.19% compared to the previous year. On the other hand, the EPS for the last quarter improved to -$1.60, showing a 67.43% increase from the previous quarter.

Overall, Run stock performances on February 26, 2024, demonstrated a mixed picture with flat total revenue, improved net income from the previous quarter, and an increase in earnings per share. Investors may want to closely monitor Run’s financial performance in the coming quarters to assess its long-term growth potential.

Tags: RUN
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
MMM stock news

Analysts Bullish on AerCap Holdings with Positive Rating and Increased Price Target

Biotechnology Stock Bull Market

Title Request for Access to Google Docs Content

Healthcare cloud based

R1 RCM Stock Surges Following Lucrative Acquisition Offer

Recommended

Transportation Stock Bull Market

JR Kyushu Implements AIPowered AMD Kria K26 SOM for Enhanced Track Inspection Efficiency and Safety

2 years ago
TMUS stock news

Wedbush Analyst Maintains Outperform Rating and Raises Price Target for Global Payments

2 years ago
JD.com Stock

JD.com Shares Surge on Robust Performance and Strategic Moves

3 months ago
Mobile-handsets

Palantir Technologies Reveals Revenue Projections for Q1 2024

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Procter & Gamble Shares Approach a Critical Juncture

Vital Farms Shares Face Headwinds Amid Forecast Revisions and Insider Activity

Palantir Shares: A Wall Street Divide and a Bold New Price Target

Nvidia Accelerates AI Dominance with Early Chip Launch and Strategic Expansions

Netflix Shares Under Pressure Amid High-Stakes Acquisition Battle

Marvell Technology Shares Face Conflicting Market Cues

Trending

Viking Therapeutics Stock
Analysis

Viking Therapeutics: A Tale of Clinical Progress and Insider Selling

by Felix Baarz
January 11, 2026
0

The shares of Viking Therapeutics, a biotechnology firm, are presenting investors with a conflicting narrative this week....

Astera Labs Stock

Astera Labs Shares Face Selling Pressure Amid Strong Fundamentals

January 11, 2026
Realty Income Stock

Institutional Investors Increase Stakes in Realty Income Amid Strategic Refinancing

January 11, 2026
Procter & Gamble Stock

Procter & Gamble Shares Approach a Critical Juncture

January 11, 2026
Vital Farms Stock

Vital Farms Shares Face Headwinds Amid Forecast Revisions and Insider Activity

January 11, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Viking Therapeutics: A Tale of Clinical Progress and Insider Selling
  • Astera Labs Shares Face Selling Pressure Amid Strong Fundamentals
  • Institutional Investors Increase Stakes in Realty Income Amid Strategic Refinancing

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com